Recurrence of eosinophilic pneumonia after switching from mepolizumab to tezepelumab for worsening asthma in eosinophilic granulomatosis with polyangiitis

A 50-year-old woman with eosinophilic granulomatosis with polyangiitis had maintained glucocorticoid-free remission for approximately four years with mepolizumab monotherapy. Because asthma control gradually deteriorated despite sustained control of systemic disease, mepolizumab was replaced with tezepelumab, a monoclonal antibody targeting thymic stromal lymphopoietin. Asthma symptoms improved rapidly, and fractional exhaled nitric oxide levels decreased. However, peripheral blood eosinophil counts progressively increased, and computed tomography approximately six months after the switch demonstrated recurrent eosinophilic pneumonia, with pulmonary consolidations closely resembling those at the initial presentation. Prednisolone and mepolizumab were reintroduced, resulting in rapid resolution of eosinophilia and pulmonary infiltrates. Glucocorticoids were subsequently discontinued again without recurrence. This case suggests that improvement in airway symptoms after biologic switching does not necessarily indicate adequate suppression of systemic eosinophilic inflammation. Even after prolonged glucocorticoid-free remission, replacement of interleukin-5-targeted therapy with thymic stromal lymphopoietin inhibition may permit recurrence of eosinophilic disease. Peripheral blood eosinophil counts and systemic manifestations should therefore be carefully monitored after such switching in patients with eosinophilic granulomatosis with polyangiitis.

Authors

Institutions

Publication Details

Journal
Modern Rheumatology Case Reports
Published
2026-11-19
DOI
https://doi.org/10.1093/mrcr/rxag108
Primary Topic
Vasculitis and related conditions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Recurrence of eosinophilic pneumonia after switching from mepolizumab to tezepelumab for worsening asthma in eosinophilic granulomatosis with polyangiitis

Ayaka Inoue, Takashi Yamane
Modern Rheumatology Case Reports
Vasculitis and related conditions
article

Recurrence of eosinophilic pneumonia after switching from mepolizumab to tezepelumab for worsening asthma in eosinophilic granulomatosis with polyangiitis

Ayaka Inoue, Takashi Yamane
article en

Abstract

A 50-year-old woman with eosinophilic granulomatosis with polyangiitis had maintained glucocorticoid-free remission for approximately four years with mepolizumab monotherapy. Because asthma control gradually deteriorated despite sustained control of systemic disease, mepolizumab was replaced with tezepelumab, a monoclonal antibody targeting thymic stromal lymphopoietin. Asthma symptoms improved rapidly, and fractional exhaled nitric oxide levels decreased. However, peripheral blood eosinophil counts progressively increased, and computed tomography approximately six months after the switch demonstrated recurrent eosinophilic pneumonia, with pulmonary consolidations closely resembling those at the initial presentation. Prednisolone and mepolizumab were reintroduced, resulting in rapid resolution of eosinophilia and pulmonary infiltrates. Glucocorticoids were subsequently discontinued again without recurrence. This case suggests that improvement in airway symptoms after biologic switching does not necessarily indicate adequate suppression of systemic eosinophilic inflammation. Even after prolonged glucocorticoid-free remission, replacement of interleukin-5-targeted therapy with thymic stromal lymphopoietin inhibition may permit recurrence of eosinophilic disease. Peripheral blood eosinophil counts and systemic manifestations should therefore be carefully monitored after such switching in patients with eosinophilic granulomatosis with polyangiitis.

Modern Rheumatology Case Reports
Kakogawa Central City Hospital (JP)
Vasculitis and related conditions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon